tiprankstipranks
Dermata Therapeutics (DRMA)
NASDAQ:DRMA
US Market

Dermata Therapeutics (DRMA) Income Statement

Compare
123 Followers

Dermata Therapeutics Income Statement

Last quarter (Q3 2024), Dermata Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Dermata Therapeutics's net income was $-3.17M. See Dermata Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ -322.00
Operating Expenses
$ 12.51B$ 8.04M$ 9.67M$ 7.86M$ 3.17M
Depreciation and Amortization
$ 0.00$ 8.04M$ 9.67M$ 322.00$ 322.00
EBITDA
$ -12.51B$ 247.22K$ 0.00$ -7.86M$ -3.17M
Operating Income
$ -12.51B$ -8.04M$ -9.67M$ -7.86M$ -3.17M
Other Income/Expenses
$ 225.78M$ 247.22K$ 63.57K$ -45.61K$ -63.68K
Pretax Income
$ -12.29B$ -7.79M$ -9.61M$ -7.90M$ -3.24M
Net Income
$ -12.29B$ -7.79M$ -9.61M$ -7.95M$ -3.43M
Per Share Metrics
Basic EPS
$ -8.03K$ -40.18$ -13.92$ -15.27$ -6.60
Diluted EPS
$ -8.03K$ -39.98$ -13.92$ -15.27$ -6.60
Weighted Average Shares Outstanding
1.53M 194.00K 690.67K 520.54K 520.54K
Weighted Average Shares Outstanding (Diluted)
1.53M 194.96K 690.67K 520.54K 520.54K
Currency in USD

Dermata Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis